Intesa Sanpaolo S.p.A. »

Halozyme Therapeutics shares owned by Intesa Sanpaolo S.p.A.

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Intesa Sanpaolo S.p.A. from 13F filings

Historical chart of Intesa Sanpaolo S.p.A. investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Intesa Sanpaolo S.p.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Intesa Sanpaolo S.p.A.

Quarter filed Position value Share count Share price at filing
2026-06-30 $603k 7.7k 78.27

More positions owned by Intesa Sanpaolo S.p.A.

Space Exploration Techn Corp Class A Com Stk (SPCX)
Astrazeneca Ord (AZN)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
Stellantis SHS (STLA)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Ferrari Nv Ord (RACE)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Nike CL B (NKE)
Apple (AAPL)
Palo Alto Networks (PANW)
Totalenergies Se Act (TTE)
Abbvie (ABBV)

View all positions for Intesa Sanpaolo S.p.A.

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Alliancebernstein

View all funds holding Halozyme Therapeutics